Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2003
11/04/2003US6642267 Side effect reduction over opioid analgesics; analgesic and/or anxiolytic action
11/04/2003US6642255 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642250 1,8-naphthyridin-2(1H)-one derivatives
11/04/2003US6642246 Quinuclidine acrylamides
11/04/2003US6642241 Alkylamino- substituted dihydropyrimido-(4,5-d)pyrimidinone derivatives, inhibitors of p38,
11/04/2003US6642240 Treating emesis in a mammal
11/04/2003US6642239 Dipeptide nitrile cathepsin K inhibitors
11/04/2003US6642235 Administering a therapeutically effective amount of a formulation comprising compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of 5000; for selectively inhibiting reuptake of norepinephrine
11/04/2003US6642233 Strong affinity and high selectivity for the human NK1 receptors of substance P.
11/04/2003US6642230 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
11/04/2003US6642227 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
11/04/2003US6642226 Such as cis-(3,5-bis-trifluoromethyl-phenyl)-(4-(4-methyl-piperazin-1-yl),-3-phenyl -piperidin-1-yl)-methanone; for treatment of diseases related to neurokinin receptors
11/04/2003US6642223 Benzoheterocyclic derivatives
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/04/2003US6642216 Osteoporosis, periodontal diseases
11/04/2003US6642212 Health supplement comprising naturally occurring phytoestrogen selected from any two or more of genistein, daidzein and/or their glycosides
11/04/2003US6642201 Use of a dipeptide for stimulating repair processes
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6641808 Composition for treatment of obesity
11/04/2003CA2266006C Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
11/04/2003CA2188283C Substituted 1,3-oxathiolanes with antiviral properties
11/04/2003CA2078517C Process for the preparation of omeprazole
10/2003
10/30/2003WO2003089933A1 Uses of the carbamoyl phosphate synthesis 1 (cps 1) and the fragments thereof for the diagnosis of inflammatory diseases and sepsis
10/30/2003WO2003089619A2 Placental derived stem cells and uses thereof
10/30/2003WO2003089583A2 Tissue specific genes and gene clusters
10/30/2003WO2003089450A2 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003WO2003089439A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
10/30/2003WO2003089438A1 Labeled oxazinocarbazoles as diagnostic agents
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089430A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003WO2003089429A1 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
10/30/2003WO2003089411A1 Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
10/30/2003WO2003089410A1 Phenylalanine derivative
10/30/2003WO2003089409A1 Compounds having affinity at 5ht2c receptor and use thereof in therapy
10/30/2003WO2003089405A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
10/30/2003WO2003089010A1 Glycodendrimers having biological activity
10/30/2003WO2003088992A1 Novel screening method
10/30/2003WO2003088987A1 Composition obtained from barley shochu stillage and having effects of inhibiting the onset of alcoholic liver injury and healing it as well as favorable taste, and process for producing the same
10/30/2003WO2003088986A1 Curcumin for the prevention and/or treatment of tissue damage
10/30/2003WO2003088984A1 Compositions and methods for augmenting kidney function
10/30/2003WO2003088981A1 Methods of treating necrotizing enterocolitis
10/30/2003WO2003088977A1 (20S)-1α-HYDROXY-2α-METHYL AND 2β-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088967A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003WO2003088956A1 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
10/30/2003WO2003088955A1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amine and lactic acid or a lactic acid salt
10/30/2003WO2003088945A1 Aerosol containing a particulate active substance
10/30/2003WO2003088923A2 Methods of treating ileus
10/30/2003WO2003088908A2 Heterocyclo inhibitors of potassium channel function
10/30/2003WO2003088900A2 Solid forms of salts with tyrosine kinase activity
10/30/2003WO2003088748A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003051274A3 Benzodiazepine derivatives, preparation thereof and use thereof
10/30/2003WO2003040310A3 Novel epidermal growth factor protein and gene, and methods of use therefor
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003028527A3 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003018836A3 Model of autoimmune disease and methods for identifying agents against autoimmune disease
10/30/2003WO2003018619A3 Antimicrobial and anti-inflammatory peptides
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003004501A3 (hetero) aryl substituted benzofurans as 5-ht ligands
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002070741A3 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002060474A3 Mixtures of mushroom enzymes and the use thereof for treating maldigestion
10/30/2003WO2002060276A8 Combination of probiotics
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002032447A3 Cell damage inhibitor
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030203962 Purified plant proanthocyanidin extract, capable of inhibiting agglutination of P-type Escherichia coli and not capable of inhibiting agglutination of type 1 Escherichia coli; proanthocyanidin having 4-12 epicatechin flavanoid units
10/30/2003US20030203955 Administering to a patient suffering from an immune cell mediated diseases a therapeutic amount of biheterocyclic compound containing sulfone group or substituted suflone
10/30/2003US20030203948 Compounds having anti-hepatitics c virus effect
10/30/2003US20030203945 Coupling a heterocyclic compound containing amine group with a 4-nitrophenyl-1-oxycarbonyl or derivative useful for the treatment of neurological conditions
10/30/2003US20030203939 Administration of an isoxazole derivative as Farnesoid X Receptor(FXR) ligand for the treatment of liver disease (cholestasis)
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203919 Dipeptide nitrile cathepsin K inhibitors
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203913 Beta3 adrenergic receptor agonists and uses thereof
10/30/2003US20030203906 Novel substituted diamine derivatives useful as motlin antagonists
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203903 Administering a rifamycin microbiocides for treating infections caused by Mycobacterium tuberculosis, Mycobacterium avium complex, Chlamydia pneumoniae or Helicobacter pylori
10/30/2003US20030203893 Benzimidazole derivatives, preparation and therapeutic use thereof
10/30/2003US20030203889 Phenylsulphonyl derivatives as 5-HT receptor ligands
10/30/2003US20030203882 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer
10/30/2003US20030203857 Remedies
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203850 Transdifferentiation of pancreatic acinar cells
10/30/2003US20030203463 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030203057 A mixture of isoflavones or isoflavone glycosides, pungent, bitter and sour substances and/or scymnol and scymnol esters; secretion of biogenic monoamines; antidepressants; seasonal affective disorder; Alzheimer's disease and much more!
10/30/2003US20030203055 Administering a selective norepinephrine norepinephrine-serotonin reuptake inhibitor, e.g., milnacipran, that is not a tricylcic antidepressant; gastrointestinal and urogenital disorders; analgesics
10/30/2003US20030203052 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
10/30/2003US20030203018 Stable oral pharmaceutical dosage forms
10/30/2003US20030202979 Mixture of lecithin and polymer
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030202957 Aqueous mixture of salt and polyoxyethylene glycol; laxative
1 ... 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 ... 1258